Your browser doesn't support javascript.
loading
STAT3 Inhibitor ODZ10117 Suppresses Glioblastoma Malignancy and Prolongs Survival in a Glioblastoma Xenograft Model.
Kim, Byung-Hak; Lee, Haeri; Park, Cheol Gyu; Jeong, Ae Jin; Lee, Song-Hee; Noh, Kum Hee; Park, Jong Bae; Lee, Chung-Gi; Paek, Sun Ha; Kim, Hyunggee; Ye, Sang-Kyu.
Afiliação
  • Kim BH; Department of Pharmacology, Seoul National University College of Medicine, Seoul 03080, Korea.
  • Lee H; Biomedical Science Project (BK21PLUS), Seoul National University College of Medicine, Seoul 03080, Korea.
  • Park CG; CYTUS H&B Corporation, Cheongju 28159, Korea.
  • Jeong AJ; Department of Pharmacology, Seoul National University College of Medicine, Seoul 03080, Korea.
  • Lee SH; Biomedical Science Project (BK21PLUS), Seoul National University College of Medicine, Seoul 03080, Korea.
  • Noh KH; Department of Biotechnology, School of Life Sciences and Biotechnology, Korea University, Seoul 02841, Korea.
  • Park JB; Department of Pharmacology, Seoul National University College of Medicine, Seoul 03080, Korea.
  • Lee CG; Biomedical Science Project (BK21PLUS), Seoul National University College of Medicine, Seoul 03080, Korea.
  • Paek SH; Department of Pharmacology, Seoul National University College of Medicine, Seoul 03080, Korea.
  • Kim H; Biomedical Science Project (BK21PLUS), Seoul National University College of Medicine, Seoul 03080, Korea.
  • Ye SK; Department of Pharmacology, Seoul National University College of Medicine, Seoul 03080, Korea.
Cells ; 9(3)2020 03 15.
Article em En | MEDLINE | ID: mdl-32183406

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glioblastoma / Fator de Transcrição STAT3 Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glioblastoma / Fator de Transcrição STAT3 Idioma: En Ano de publicação: 2020 Tipo de documento: Article